Lessee, Operating Lease, Liability, to be Paid, Year One in USD of INTEGRATED BIOPHARMA INC from Q3 2018 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Integrated Biopharma Inc quarterly Lessee, Operating Lease, Liability, to be Paid, Year One history and change rate from Q3 2018 to Q4 2024.
  • Integrated Biopharma Inc Lessee, Operating Lease, Liability, to be Paid, Year One for the quarter ending 31 Dec 2024 was $661K.
Lessee, Operating Lease, Liability, to be Paid, Year One, Quarterly (USD)

INTEGRATED BIOPHARMA INC Quarterly Lessee, Operating Lease, Liability, to be Paid, Year One (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $661K 31 Dec 2024 10-Q 13 Feb 2025
Q3 2024 $660K 30 Sep 2024 10-Q 13 Nov 2024
Q2 2021 $582K 30 Jun 2021 10-K 02 Sep 2021
Q3 2018 $442K 30 Sep 2018 10-Q 09 Nov 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.